Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BL-1020 Mesylate (CYP-1020 Mesylate) is an orally available GABA A receptor agonist and D2 antagonist that decreases dopamine activity and enhances GABAA activity.BL-1020 Mesylate has been used in the study of schizophrenia, Alzheimer's disease, and bi-directional cognitive impairment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 |
Description | BL-1020 Mesylate (CYP-1020 Mesylate) is an orally available GABA A receptor agonist and D2 antagonist that decreases dopamine activity and enhances GABAA activity.BL-1020 Mesylate has been used in the study of schizophrenia, Alzheimer's disease, and bi-directional cognitive impairment. |
Synonyms | CYP-1020 Mesylate |
Molecular Weight | 777.39 |
Formula | C28H45ClN4O11S4 |
CAS No. | 916898-61-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BL-1020 Mesylate 916898-61-8 GPCR/G Protein Membrane transporter/Ion channel Neuroscience Dopamine Receptor GABA Receptor BL-1020 CYP-1020 AN168 CYP-1020 Mesylate CYP1020 BL 1020 BL1020 Perphenazine GABA ester BL 1020 Mesylate BL1020 Mesylate AN 168 AN-168 CYP 1020 inhibitor inhibit